Comparison between MyoRing and 355°KERATACx in the management of keratoconus

Background Intracorneal implants have been proposed over the years as a possible easier way for managing keratoconus, having a favorable influence on the course of the disease. KERATACx is a relatively new form of intracorneal ring segments that has been recently introduced but not thoroughly studied regarding its safety and efficacy. Moreover, implanting a complete intrastromal ring into a corneal pocket, MyoRing (Dioptex GmbH, Austria), is an alternative technique, which can be considered safe, effective, and relatively easy for the treatment of keratoconus. Aim To compare between the effect of MyoRing and KERATACx corneal implants as new modalities of treatment on the visual acuity, as well as assess corneal topography findings in cases with moderate to severe keratoconus. Patients and methods Our study is a prospective comparative study conducted at specialized eye centers in Cairo. A total of 20 keratoconic eyes were eventually recruited. Overall, 10 of those eyes had 355° intracorneal ring segment implants (KERATACx ring segments) inserted into a femtosecond laser-created corneal tunnel at a depth of 75% of the thinnest location at the proposed tunnel site (group A), whereas the other 10 eyes had complete ring (MyoRing) implantation into a femtosecond laser-created corneal pocket at a 300-μm corneal depth (group B), by the same designated surgeon. The study was approved by the Ethics Committee of Ain-Shams University. Results Both types were proven to be statistically effective, with no statistically significant differences between the two groups related to any of the followed up parameters. In fact, both proved safe, effective, and reliable methods for managing keratoconus, with no difference of importance even to the degree of myopic refractive error correction. There were no significant intraoperative or postoperative complications reported within both groups throughout the whole study and follow-up period, but in turn, stability of the achieved results was found in both groups. Conclusion Both MyoRing and KERATACx were found to be equally effective, safe, and reliable methods for keratoconus management